Literature DB >> 24413082

Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function.

G J Rahme1, M A Israel2.   

Abstract

Tumor cell invasion is a major contributor to cancer morbidity, and is of particular importance in patients with glioblastoma multiforme (GBM), the highest grade and most aggressive primary brain tumor. Tumor cell invasion and the expression of matrix metalloproteinases (MMPs), which are required for GBM invasion, are enhanced by inhibitor of DNA binding (Id) gene family members, Id1, Id2 and Id3, which can be highly expressed in glioma. Id4 is expressed in GBM at more variable levels than these other family members and we sought to determine its role in invasion. We found, unexpectedly, that invasion was dramatically inhibited in cells expressing Id4 as a result of decreased MMP2, a secreted proteinase key for brain tumor invasion. We demonstrate that Id4 decreased MMP2 expression by a direct inhibitory interaction with Twist1, a basic helix-loop-helix transcription factor known to increase MMP2 expression. Importantly, using data from The Cancer Genome Atlas, we show that Id4 expression correlates with survival of glioblastoma patients and inversely correlates with MMP2 expression. These data suggest that the upregulation of MMP2 resulting from decreased Id4 expression in GBM may contribute to the morbidity and mortality of GBM patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24413082     DOI: 10.1038/onc.2013.531

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  57 in total

Review 1.  Id genes in nervous system development.

Authors:  P J Andres-Barquin; M C Hernandez; M A Israel
Journal:  Histol Histopathol       Date:  2000-04       Impact factor: 2.303

2.  Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels.

Authors:  P M Kuzontkoski; M J Mulligan-Kehoe; B T Harris; M A Israel
Journal:  Oncogene       Date:  2010-05-10       Impact factor: 9.867

3.  Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL.

Authors:  Shih-Shih Chen; Rainer Claus; David M Lucas; Lianbo Yu; Jiang Qian; Amy S Ruppert; Derek A West; Katie E Williams; Amy J Johnson; Fred Sablitzky; Christoph Plass; John C Byrd
Journal:  Blood       Date:  2010-11-22       Impact factor: 22.113

4.  Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.

Authors:  Silvia Coma; Dhara N Amin; Akio Shimizu; Anna Lasorella; Antonio Iavarone; Michael Klagsbrun
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

5.  Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites.

Authors:  H Nakamura; Y Fujii; I Inoki; K Sugimoto; K Tanzawa; H Matsuki; R Miura; Y Yamaguchi; Y Okada
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

6.  Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.

Authors:  Naoyuki Umetani; Takuji Mori; Kazuo Koyanagi; Masaru Shinozaki; Joseph Kim; Armando E Giuliano; Dave S B Hoon
Journal:  Oncogene       Date:  2005-07-07       Impact factor: 9.867

7.  Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.

Authors:  Tao Sun; Nan Zhao; Xiu-Lan Zhao; Qiang Gu; Shi-Wu Zhang; Na Che; Xing-Hui Wang; Jing Du; Yi-Xin Liu; Bao-Cun Sun
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

8.  Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor.

Authors:  Ryouichi Tsunedomi; Norio Iizuka; Takao Tamesa; Kazuhiko Sakamoto; Takashi Hamaguchi; Hideaki Somura; Mamoru Yamada; Masaaki Oka
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

9.  Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo.

Authors:  R E Sawaya; M Yamamoto; Z L Gokaslan; S W Wang; S Mohanam; G N Fuller; I E McCutcheon; W G Stetler-Stevenson; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

10.  Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.

Authors:  P A Forsyth; H Wong; T D Laing; N B Rewcastle; D G Morris; H Muzik; K J Leco; R N Johnston; P M Brasher; G Sutherland; D R Edwards
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  29 in total

1.  Effects of hnRNP A2/B1 Knockdown on Inhibition of Glioblastoma Cell Invasion, Growth and Survival.

Authors:  Jinmu Deng; Song Chen; Feng Wang; Hongxin Zhao; Zongyi Xie; Zhongye Xu; Qingtao Zhang; Ping Liang; Xuan Zhai; Yuan Cheng
Journal:  Mol Neurobiol       Date:  2015-01-14       Impact factor: 5.590

Review 2.  Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities.

Authors:  John Glod; Gilbert J Rahme; Harpreet Kaur; Eric H Raabe; Eugene I Hwang; Mark A Israel
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

3.  Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.

Authors:  Pankaj Sharma; Swathi Chinaranagari; Jaideep Chaudhary
Journal:  Biochimie       Date:  2015-03-13       Impact factor: 4.079

Review 4.  Inhibitor of differentiation 4 (ID4): From development to cancer.

Authors:  Divya Patel; Derrick J Morton; Jason Carey; Mathew C Havrda; Jaideep Chaudhary
Journal:  Biochim Biophys Acta       Date:  2014-12-12

5.  Regulatory T cells are not a strong predictor of survival for patients with glioblastoma.

Authors:  Alissa A Thomas; Jan L Fisher; Gilbert J Rahme; Thomas H Hampton; Udo Baron; Sven Olek; Tim Schwachula; C Harker Rhodes; Jiang Gui; Laura J Tafe; Gregory J Tsongalis; Joel A Lefferts; Heather Wishart; Jonathan Kleen; Michael Miller; Chery A Whipple; Francine B de Abreu; Marc S Ernstoff; Camilo E Fadul
Journal:  Neuro Oncol       Date:  2015-01-24       Impact factor: 12.300

6.  TWIST1 methylation by SETD6 selectively antagonizes LINC-PINT expression in glioma.

Authors:  Lee Admoni-Elisha; Tzofit Elbaz; Anand Chopra; Guy Shapira; Mark T Bedford; Christopher J Fry; Noam Shomron; Kyle Biggar; Michal Feldman; Dan Levy
Journal:  Nucleic Acids Res       Date:  2022-06-13       Impact factor: 19.160

7.  Carboxyethylpyrroles: From Hypothesis to the Discovery of Biologically Active Natural Products.

Authors:  Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-11-02       Impact factor: 3.739

8.  LncRNA and mRNA expression profiles of glioblastoma multiforme (GBM) reveal the potential roles of lncRNAs in GBM pathogenesis.

Authors:  Qi Li; Hongmei Jia; Haowen Li; Chengya Dong; Yajie Wang; Zhongmei Zou
Journal:  Tumour Biol       Date:  2016-09-08

9.  A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.

Authors:  Gilbert J Rahme; Bryan W Luikart; Chao Cheng; Mark A Israel
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

10.  The Heterodimeric TWIST1-E12 Complex Drives the Oncogenic Potential of TWIST1 in Human Mammary Epithelial Cells.

Authors:  Laurent Jacqueroud; Charlotte Bouard; Geoffrey Richard; Léa Payen; Mojgan Devouassoux-Shisheboran; Douglas B Spicer; Julie Caramel; Guillaume Collin; Alain Puisieux; Agnès Tissier; Stéphane Ansieau
Journal:  Neoplasia       Date:  2016-05       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.